Approval for removal of the pcrformaxx grip on the delivery system, the addition of a smaller packaging configuration, and minor labeling changes. the device, as modified, will be marketed under the trade name lifestar vascular stent system and is indicated for the treatment of iliac occlusive disease in patients with symptomatic vascular disease of the common and/or external iliac arteries up to 126 mm in length with a reference vessel diameter of 5 to 9 mm.